Concepedia

Publication | Open Access

Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin

DOIFull Paper Access

218

Citations

13

References

2013

Year

Ele Ferrannini, Andreas Berk, Stefan Hantel, Sabine Pinnetti, Thomas Hach, Hans J. Woerle, Uli C. Broedl
Diabetes Care

Abstract

Long-term empagliflozin treatment provided sustained glycemic and weight control and was well tolerated with a low risk of hypoglycemia in patients with type 2 diabetes.

References

YearCitations

Page 1